The findings were correlated with a highly expressed cognate receptor of HGF/c-Met during inflammation and in cancer-associated lymphatic vessels in both in vitro and in vivo studies, suggesting a direct role of HGF with LECs [116,117,118]. The gene discussed is HGF; the disease is cancer.